Metraipolis › archive › dc_57d74882a67c
From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics — Europe PMC PMID:41210172
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41210172
- DOI
- 10.1016/j.omtm.2025.101613
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T10:02:01.456Z
- SHA-256 of the archived text
42ee7168dfe951884aa8e02e824e6617cc9765536d6e0d0873b83f891f546ac4- Stable URL of this page
https://metraipolis.com/documento/dc_57d74882a67c
How to cite
From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics — Europe PMC PMID:41210172 — Europe PMC (en), https://europepmc.org/article/MED/41210172 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57d74882a67c (Metraipolis archive dc_57d74882a67c, sha256 42ee7168dfe951884aa8e02e824e6617cc9765536d6e0d0873b83f891f546ac4)
BibTeX
@misc{dc57d74882a67c,
title = {From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics — Europe PMC PMID:41210172},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41210172},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57d74882a67c; sha256 42ee7168dfe951884aa8e02e824e6617cc9765536d6e0d0873b83f891f546ac4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41210172. Agents can read the archived copy with the MCP tool read_document.